Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tolerance in the Age of Immunotherapy
Jeffrey A. Bluestone, Mark S. Anderson
New England Journal of Medicine (2020) Vol. 383, Iss. 12, pp. 1156-1166
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Pathogenesis of autoimmune disease
David S. Pisetsky
Nature Reviews Nephrology (2023) Vol. 19, Iss. 8, pp. 509-524
Open Access | Times Cited: 279
Immune-mediated inflammatory disease therapeutics: past, present and future
Iain B. McInnes, Ellen M. Gravallese
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 680-686
Open Access | Times Cited: 208
Emerging concepts in PD-1 checkpoint biology
Kristen E. Pauken, James A. Torchia, Apoorvi Chaudhri, et al.
Seminars in Immunology (2021) Vol. 52, pp. 101480-101480
Open Access | Times Cited: 134
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yuheng Yan, Lan Huang, Yiming Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 114
The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation
Kamal D. Moudgil, Shivaprasad H. Venkatesha
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 95-95
Open Access | Times Cited: 103
Ferroptosis: a double-edged sword mediating immune tolerance of cancer
Qin Dang, Ziqi Sun, Yang Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 80
RBP–RNA interactions in the control of autoimmunity and autoinflammation
Juan Liu, Xuetao Cao
Cell Research (2023) Vol. 33, Iss. 2, pp. 97-115
Open Access | Times Cited: 43
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
Weishi Cheng, Kai Kang, Ailin Zhao, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30
The interaction of innate immune and adaptive immune system
Ruyuan Wang, Caini Lan, Kamel Benlagha, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 18
Immune Tolerance Regulation Is Critical to Immune Homeostasis
Lei Han, Ta-Jen Wu, Qin Zhang, et al.
Journal of Immunology Research (2025) Vol. 2025, Iss. 1
Open Access | Times Cited: 2
Type 1 diabetes mellitus: much progress, many opportunities
Alvin C. Powers
Journal of Clinical Investigation (2021) Vol. 131, Iss. 8
Open Access | Times Cited: 103
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies
Alan H. Baik, Olalekan O. Oluwole, Douglas B. Johnson, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1780-1801
Open Access | Times Cited: 87
HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance
Baimei Zhuang, Jin Shang, Yuanqing Yao
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation
Katharina Schreeb, Emily J Culme-Seymour, Essra Ridha, et al.
Kidney International Reports (2022) Vol. 7, Iss. 6, pp. 1258-1267
Open Access | Times Cited: 39
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
Amir Munir, Alan Gutierrez, Juan Qin, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 540-553
Closed Access | Times Cited: 11
The persistent inflammation in COPD: is autoimmunity the core mechanism?
Lingling Dong, Zhengyuan Liu, Kaijun Chen, et al.
European Respiratory Review (2024) Vol. 33, Iss. 171, pp. 230137-230137
Open Access | Times Cited: 9
Unique skin nodules following COVID-19 vaccination: a case report of cutaneous plasmacytosis and review of the literature
Xiaoxi Xu, Wuwu Ding, Haizhen Song, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy
Elena Goleva, Taras Lyubchenko, Lukas Kraehenbuehl, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 6, pp. 630-638
Open Access | Times Cited: 43
Regulation of activated T cell survival in rheumatic autoimmune diseases
Florencia Rosetti, Iris K. Madera‐Salcedo, Noé Rodríguez‐Rodríguez, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 4, pp. 232-244
Closed Access | Times Cited: 37
Type 1 regulatory T cell-mediated tolerance in health and disease
Robert A. Freeborn, Steven Strubbe, Maria Grazia Roncarolo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
Zhiqing Xiang, Xiangli Yin, Leiyan Wei, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 8
Control of inflammation using non-invasive neuromodulation: past, present and promise
Aisling Tynan, Michael Brines, Sangeeta S. Chavan
International Immunology (2021) Vol. 34, Iss. 2, pp. 119-128
Open Access | Times Cited: 33
Recent advances of nanotechnology application in autoimmune diseases – A bibliometric analysis
Rendong He, Li Li, Tingjun Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101694-101694
Closed Access | Times Cited: 25
Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus
David S. Pisetsky
Arthritis & Rheumatology (2024) Vol. 76, Iss. 9, pp. 1334-1343
Closed Access | Times Cited: 5
Antigen-specific immunotherapies in type 1 diabetes
Xuejiao Zhang, Ying Dong, Dianyuan Liu, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 73, pp. 127040-127040
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top